DORMHIGH SIGNALFINANCIAL10-K

DORM's operating cash flow declined substantially while inventory levels surged, indicating significant working capital pressures and potential demand or operational challenges.

The substantial reduction in operating cash flow combined with a major inventory build suggests the company may be experiencing demand softness or supply chain inefficiencies that are tying up significant capital. The shift from 81% to 76% branded product sales indicates increased reliance on lower-margin private label business, which could pressure future profitability despite current gross profit growth.

Comparing 2026-02-27 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

DORM's financial profile shows concerning working capital dynamics, with operating cash flow declining substantially to $113.6M while inventory expanded significantly to $959M, representing a major capital deployment shift. The company improved gross profit modestly to $897.7M and strengthened its balance sheet with higher stockholders' equity and reduced current liabilities. However, the sharp deterioration in cash generation relative to inventory investment suggests potential operational challenges that warrant close monitoring despite the improved gross profitability metrics.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-50.8%
$231.0M→$113.6M

Operating cash flow fell 50.8% — earnings quality concerns; investigate working capital changes and non-cash items.

Inventory
Balance Sheet
+35.5%
$708.0M→$959.0M

Inventory surged 35.5% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Accounts Receivable
Balance Sheet
-16.5%
$573.8M→$479.3M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Stockholders Equity
Balance Sheet
+14.2%
$1.3B→$1.5B

Equity base grew 14.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Cash & Equivalents
Balance Sheet
-13.5%
$57.1M→$49.4M

Cash decreased 13.5% — monitor burn rate and upcoming capital needs.

Current Liabilities
Balance Sheet
-12.6%
$563.8M→$492.8M

Current liabilities reduced — improved short-term financial position and working capital health.

Gross Profit
P&L
+11.3%
$806.4M→$897.7M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Current Assets
Balance Sheet
+11.1%
$1.4B→$1.5B

Current assets grew 11.1% — improving short-term liquidity or inventory/receivables build.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-27
ADDED
As of February 24, 2026, the registrant had 30,183,260 shares of common stock, $0.01 par value, outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 27 ITEM 7A.
The Company is under no obligation to (and expressly disclaims any such obligation to) update any of the information in this report if any forward-looking statement later turns out to be inaccurate, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.
As of December 31, 2025, we marketed approximately 144,000 distinct parts compared to approximately 138,000 as of December 31, 2024, many of which we designed and engineered.
Our products are sold under our various brand names, under our customers private-label brands, or in bulk.
+7 more — sign up free →
REMOVED
As of February 24, 2025, the registrant had 30,581,562 shares of common stock, $0.01 par value, outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 31 ITEM 7A.
The Company is under no obligation to (and expressly disclaims any such obligation to) update any of the information in this report if any forward-looking statement later turns out to be inaccurate whether as a result of new information, future events or otherwise.
As of December 31, 2024, we marketed approximately 138,000 distinct parts compared to approximately 133,000 as of December 31, 2023, many of which we designed and engineered.
Our products are sold under our various brand names, under our customers private label brands, or in bulk.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →